Refine
Year of publication
Language
- English (31)
Has Fulltext
- yes (31)
Is part of the Bibliography
- no (31)
Keywords
- Multiple sclerosis (2)
- Neuroinflammation (2)
- ceramides (2)
- inflammation (2)
- macrophage (2)
- pain (2)
- sphingolipids (2)
- sphingosine kinase (2)
- stroke (2)
- A498 cells (1)
- AMP-activated kinase (1)
- Acquired resistance (1)
- Acute lymphoblastic leukemia (1)
- Acute myeloid leukemia (1)
- Adenylyl cyclase (1)
- Autoimmune encephalomyelitis (1)
- Biomarkers (1)
- Brain injury (1)
- CNDAC (1)
- CTGF (1)
- CYP1A1 (1)
- Cancer (1)
- DCK (1)
- DNA damage (1)
- Diagnostic markers (1)
- Entorhinal cortex lesion (1)
- FTY720 (1)
- G-protein-coupled receptors (1)
- G2A (1)
- GEMs (1)
- GPCR (1)
- Glycolysis (1)
- Gαq/11 (1)
- HCC marker (1)
- HIV (1)
- HIV-1 (1)
- IFN-β (1)
- Intrinsic resistance (1)
- Leukemia (1)
- Lipid signaling (1)
- Lpar2 (1)
- Lysophosphatidic acids (1)
- MLV (1)
- MRP4 (1)
- Mitochondrial ROS (1)
- Nociception (1)
- Oncology (1)
- Oxidative phosphorylation (1)
- PKA (1)
- PRG-1 (1)
- RCC (1)
- S1P receptors (1)
- SAMHD1 (1)
- SAMHD1 knockout mouse (1)
- SAMHD1 phosphorylation (1)
- Sapacitabine (1)
- Spinal cord (1)
- Structural plasticity (1)
- T-cell homing (1)
- acute inflammation (1)
- adenosine receptors (1)
- analgesia (1)
- angiopoietin-like 3 (ANGPTL3) (1)
- beta blockade (1)
- bioactive lipids (1)
- bioactive phospholipids (1)
- biomarker (1)
- blood pressure (1)
- breast cancer (1)
- cAMP (1)
- caloric restriction (1)
- cannabinoid receptor type 1 (1)
- cortical network (1)
- data science (1)
- dendritic cells (1)
- eNPP2 (1)
- endocannabinoids (1)
- epigenetics (1)
- exercise (1)
- fibrosarcoma (1)
- glucose metabolism (1)
- graft rejection (1)
- hepatitis C (1)
- histone deacetylase (1)
- human pain models (1)
- human pharmacology (1)
- hyperglycemia (1)
- ischemic type biliary lesions (1)
- mast cells (1)
- microlesions (1)
- migration (1)
- multiple sclerosis (1)
- orthopic liver transplantation (1)
- perineurium (1)
- polarization (1)
- post-exercise hypotension (1)
- prostaglandin E (1)
- prostaglandins (1)
- psychiatric disorders (1)
- regulatory T helper cells (1)
- resolution (1)
- sciatic nerve (1)
- smooth muscle cells (1)
- sphingolipid (1)
- sphingosine 1-phosphate (1)
- sphingosine 1-phosphate homologues (1)
- sphingosine 1-phosphate receptor (1)
- sphingosine-1-phosphate (1)
- synapse (1)
- toll-like receptor (1)
- tumor pain (1)
- vascular biology (1)
- xenobiotics (1)
- fingolimod (1)
Institute
- Medizin (29)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (6)
- Biochemie, Chemie und Pharmazie (2)
- Biowissenschaften (2)
- Pharmazie (2)
- Sonderforschungsbereiche / Forschungskollegs (2)
- Institut für Ökologie, Evolution und Diversität (1)
- Interdisziplinäres Zentrum für Neurowissenschaften Frankfurt (IZNF) (1)
- Senckenbergische Naturforschende Gesellschaft (1)
Hepatitis C virus (HCV) substantially affects lipid metabolism, and remodeling of sphingolipids appears to be essential for HCV persistence in vitro. The aim of the current study is the evaluation of serum sphingolipid variations during acute HCV infection. We enrolled prospectively 60 consecutive patients with acute HCV infection, most of them already infected with human immunodeficiency virus (HIV), and serum was collected at the time of diagnosis and longitudinally over a six-month period until initiation of antiviral therapy or confirmed spontaneous clearance. Quantification of serum sphingolipids was performed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Spontaneous clearance was observed in 11 out of 60 patients (18.3%), a sustained viral response (SVR) in 43 out of 45 patients (95.5%) receiving an antiviral treatment after follow-up, whereas persistence of HCV occurred in six out of 60 patients (10%). C24-ceramide (C24-Cer)-levels increased at follow-up in patients with spontaneous HCV eradication (p < 0.01), as compared to baseline. Sphingosine and sphinganine values were significantly upregulated in patients unable to clear HCV over time compared to patients with spontaneous clearance of HCV infection on follow-up (p = 0.013 and 0.006, respectively). In summary, the persistence of HCV after acute infection induces a downregulation of C24Cer and a simultaneous elevation of serum sphingosine and sphinganine concentrations.